1Anderson NG;Anderson NL.Proteome and proteomics:new technologies,new concepts and new words[J],1998(11).
2Kellner R.Proteomics.concepts and perspectives[J],2000.
3Bandara LR;Kennedy S.Toxicoproteomics - a new preclinical tool[J],2002(7).
4Spence P.Toxicoproteomics: learning to walk before it can run,2002.
5Olden K.New opportunities in toxicology in the post-genomic era,2002.
6Fountoulakis M.Proteomics: Current technologies and applications in neurological disorders and toxicology[J],2001.
7Qiu Y;Benet LZ;Burlingame AL.Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry[J],1998(28).
8Fountoulakis M;Berndt P;Boelsterli UA.Two-dimensional database of mouse liver proteins:changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regiosomer 3-acetamidophenol[J],2000(11).
9Mondacald N;Chevalier S;Tonge R.Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP)[J],2001.
10Moller A;Soldan M;Volker U.Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds[J],2001(1/3).
7Ge Y,Preston RJ.Owen RD.Toxicoproteomics and its application to human health risk assessment.Proteomics Clin,2007,1:1613-1624.
8Merrick BA.The plasma proteome,adductome and idiosyncratic toxicity in toxicoproteomics research.Brid Funct Cenomic Proteomic,2008,7:35-49.
9Gharahdaghi F, Weinberg CR, Meagher DA, et al.Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis, 1999, 20: 601-605 .
10Takatsume Y, Izawa S, Inoue Y. Identification of thermostable glyoxalase I in the fission yeast Schizosaccharomyces pombe. Arch Microbiol, 2004,181:371-377.
